sulfasalazine has been researched along with thalidomide in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kaklamani, VG; Kaklamanis, PG | 1 |
| Ayoub, N; Barete, S; Francès, C; Piette, JC | 1 |
| El Maghraoui, A | 1 |
| Kim, HJ; Lee, CK | 1 |
| Medhi, B; Pandhi, P; Prakash, O; Saikia, UN | 2 |
| Foley, P; Kelly, JB; Strober, BE | 1 |
| Pang, C; Wu, X; Xiao, P; Zhu, X | 1 |
| Braun, J | 1 |
| Barone, M; Cantarini, L; Fabiani, C; Franceschini, R; Frediani, B; Galeazzi, M; Iannone, F; Lapadula, G; Lopalco, G; Rigante, D; Venerito, V | 1 |
| Dressler, C; Eisert, L; Nast, A; Pham, PA | 1 |
| Hu, Z; Huang, F; Ji, X; Ma, Y; Man, S; Wang, Y; Zhang, J; Zhu, J | 1 |
| Huang, D; Huang, W; Luo, L; Ren, F; Tang, L; Zhang, Z; Zhou, J | 1 |
7 review(s) available for sulfasalazine and thalidomide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Ankylosing spondylitis].
Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Reactive; Behcet Syndrome; Diagnosis, Differential; Diphosphonates; Humans; Immunosuppressive Agents; Lung; Methotrexate; Pamidronate; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine; Thalidomide; Tomography, X-Ray Computed | 2004 |
[Pathogenesis and treatment of intestinal Behçet's disease].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Behcet Syndrome; Colchicine; Colitis, Ulcerative; Crohn Disease; Humans; Immunologic Factors; Prognosis; Sulfasalazine; Thalidomide; Tumor Necrosis Factor-alpha | 2007 |
Current and future oral systemic therapies for psoriasis.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Cyclosporine; Fumarates; Humans; Hydroxyurea; Immunosuppressive Agents; Isoxazoles; Keratolytic Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Sulfasalazine; Thalidomide; Thioguanine | 2015 |
New targets in psoriatic arthritis.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Cyclophosphamide; Etanercept; Humans; Infliximab; Methotrexate; Molecular Targeted Therapy; Phosphodiesterase 4 Inhibitors; Piperidines; Psoriasis; Pyrimidines; Pyrroles; Sulfasalazine; Thalidomide; Ustekinumab | 2016 |
Update on the Medical Management of Gastrointestinal Behçet's Disease.
Topics: Adrenal Cortex Hormones; Animals; Behcet Syndrome; Gastrointestinal Tract; Humans; Immunologic Factors; Mesalamine; Sulfasalazine; Thalidomide | 2017 |
Efficacy and safety of systemic treatments in psoriatic arthritis: a systematic review, meta-analysis and GRADE evaluation.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Dermatologic Agents; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infliximab; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Sulfasalazine; Thalidomide; Ustekinumab | 2019 |
8 other study(ies) available for sulfasalazine and thalidomide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chlorambucil; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferons; Levamisole; Male; Methotrexate; Pentoxifylline; Recombinant Proteins; Recurrence; Sulfasalazine; Thalidomide | 2001 |
[Classification of dermatologic manifestations in lupus erythematosus].
Topics: Acitretin; Adrenal Cortex Hormones; Adult; Antimalarials; Clinical Trials as Topic; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug Combinations; Female; Glucosamine; Humans; Hydroxychloroquine; Immunosuppressive Agents; Infant, Newborn; Isotretinoin; Keratolytic Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Male; Middle Aged; Skin; Sulfasalazine; Thalidomide; Thrombosis; Ultraviolet Therapy; Vasculitis | 2003 |
Effect of different doses of thalidomide in experimentally induced inflammatory bowel disease in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Disease Models, Animal; Female; Gastrointestinal Agents; Inflammatory Bowel Diseases; Male; Malondialdehyde; Peroxidase; Rats; Rats, Wistar; Sulfasalazine; Thalidomide; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2008 |
Effect of combination of thalidomide and sulfasalazine in experimentally induced inflammatory bowel disease in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colon; Disease Models, Animal; Drug Therapy, Combination; Female; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Rats; Rats, Wistar; Sulfasalazine; Thalidomide; Treatment Outcome; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2011 |
Clinical research for curing ankylosing spondylitis through combining etanercept, thalidomide and sulfasalazine.
Topics: Adolescent; Adult; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Male; Receptors, Tumor Necrosis Factor; Spondylitis, Ankylosing; Sulfasalazine; Thalidomide | 2015 |
Add-On Effects of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs in Ankylosing Spondylitis: Data from a Real-World Registered Study in China.
Topics: Adult; Antirheumatic Agents; Biomarkers; Blood Sedimentation; C-Reactive Protein; China; Disease Progression; Female; Humans; Male; Middle Aged; Registries; Severity of Illness Index; Spondylitis, Ankylosing; Sulfasalazine; Surveys and Questionnaires; Thalidomide; Treatment Outcome | 2020 |
Cause analysis of conversion to biologics in spondyloarthritis patients with poor response to conventional treatment.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Biological Factors; Biological Products; Humans; Spondylarthritis; Sulfasalazine; Thalidomide; Uveitis | 2023 |